2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3263 | |||||||||||||||||||||||
Submitter : | Mr. Matt LaLonde | Date & Time: | 12/14/2006 01:12:30 | |||||||||||||||||||||
Organization : | Mr. Matt LaLonde | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
I oppose the creation of any vaccine that is made from an aborted human fetus. | ||||||||||||||||||||||||